Elanco Animal Health Income from Continuous Operations 2016-2024 | ELAN

Elanco Animal Health annual/quarterly income from continuous operations history and growth rate from 2016 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Elanco Animal Health income from continuous operations for the quarter ending June 30, 2024 was $-0.050B, a 48.45% decline year-over-year.
  • Elanco Animal Health income from continuous operations for the twelve months ending June 30, 2024 was $-1.255B, a 1010.62% increase year-over-year.
  • Elanco Animal Health annual income from continuous operations for 2023 was $-1.231B, a 1478.21% increase from 2022.
  • Elanco Animal Health annual income from continuous operations for 2022 was $-0.078B, a 83.85% decline from 2021.
  • Elanco Animal Health annual income from continuous operations for 2021 was $-0.483B, a 15.85% decline from 2020.
Elanco Animal Health Annual Income from Continuous Operations
(Millions of US $)
2023 $-1,231
2022 $-78
2021 $-483
2020 $-574
2019 $68
2018 $87
2017 $-311
2016 $-48
2015 $-211
Elanco Animal Health Quarterly Income from Continuous Operations
(Millions of US $)
2024-06-30 $-50
2024-03-31 $32
2023-12-31 $-141
2023-09-30 $-1,096
2023-06-30 $-97
2023-03-31 $103
2022-12-31 $-54
2022-09-30 $-65
2022-06-30 $-10
2022-03-31 $51
2021-12-31 $-108
2021-09-30 $-104
2021-06-30 $-210
2021-03-31 $-61
2020-12-31 $-337
2020-09-30 $-135
2020-06-30 $-53
2020-03-31 $-49
2019-12-31 $-9
2019-09-30 $10
2019-06-30 $36
2019-03-31 $32
2018-12-31 $16
2018-09-30 $60
2018-06-30 $-63
2018-03-31 $73
2017-12-31
2017-09-30 $-21
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.955B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00